HK1156512A1 - High enhancer-loading polyacrylate formulation for transdermal applications - Google Patents

High enhancer-loading polyacrylate formulation for transdermal applications

Info

Publication number
HK1156512A1
HK1156512A1 HK11110824.8A HK11110824A HK1156512A1 HK 1156512 A1 HK1156512 A1 HK 1156512A1 HK 11110824 A HK11110824 A HK 11110824A HK 1156512 A1 HK1156512 A1 HK 1156512A1
Authority
HK
Hong Kong
Prior art keywords
loading
transdermal applications
high enhancer
polyacrylate
formulation
Prior art date
Application number
HK11110824.8A
Other languages
English (en)
Chinese (zh)
Inventor
Jay Audett
Jianye Wen
Eli J Goldman
Allison Luciano
Paul B Foreman
Eric N Silverberg
Robert M Gale
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of HK1156512A1 publication Critical patent/HK1156512A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK11110824.8A 2005-09-23 2011-10-12 High enhancer-loading polyacrylate formulation for transdermal applications HK1156512A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72020105P 2005-09-23 2005-09-23
US72313505P 2005-09-30 2005-09-30

Publications (1)

Publication Number Publication Date
HK1156512A1 true HK1156512A1 (en) 2012-06-15

Family

ID=37500893

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11110824.8A HK1156512A1 (en) 2005-09-23 2011-10-12 High enhancer-loading polyacrylate formulation for transdermal applications

Country Status (4)

Country Link
US (5) US8383149B2 (fr)
EP (2) EP1948142B1 (fr)
HK (1) HK1156512A1 (fr)
WO (1) WO2007035939A2 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8383149B2 (en) 2005-09-23 2013-02-26 Alza Corporation High enhancer-loading polyacrylate formulation for transdermal applications
JP5230427B2 (ja) 2005-09-23 2013-07-10 ヘンケル・アーゲー・アンド・カンパニー・カーゲーアーアー アクリルポリマー系接着剤
WO2007035940A2 (fr) 2005-09-23 2007-03-29 Alza Corporation Systeme d'administration de norelgestromine par voie transdermique
EP1928924B1 (fr) * 2005-09-23 2011-05-18 National Starch and Chemical Investment Holding Corporation Adhesifs acryliques a base de polymeres
CN101528830A (zh) 2006-07-10 2009-09-09 麦德医像公司 超弹性环氧水凝胶
WO2009026133A2 (fr) * 2007-08-17 2009-02-26 Alza Corporation Système d'administration transdermique de bisoprolol
WO2009073734A2 (fr) 2007-12-03 2009-06-11 Medipacs, Inc. Dispositif de mesure de fluide
WO2011032011A1 (fr) 2009-09-10 2011-03-17 Medipacs, Inc. Actionneur à faible encombrement et méthode améliorée d'administration d'agents thérapeutiques commandée par le soignant
ES2739469T3 (es) * 2009-12-28 2020-01-31 Teikoku Seiyaku Kk Preparación de cinta adhesiva
US20110172637A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Drug delivery device including tissue support structure
US20110172609A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Microneedle component assembly for drug delivery device
US20110172645A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Wearable drug delivery device including integrated pumping and activation elements
US20110172639A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Device and method for delivery of microneedle to desired depth within the skin
US9500186B2 (en) 2010-02-01 2016-11-22 Medipacs, Inc. High surface area polymer actuator with gas mitigating components
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
US8668675B2 (en) 2010-11-03 2014-03-11 Flugen, Inc. Wearable drug delivery device having spring drive and sliding actuation mechanism
KR101317158B1 (ko) 2011-02-18 2013-10-15 조선대학교산학협력단 갈란타민 또는 그의 염을 함유하는 경피흡수제제
WO2013113690A1 (fr) * 2012-01-31 2013-08-08 Grünenthal GmbH Timbre pharmaceutique pour l'administration transdermique de (1r,4r)-6'-fluoro-n,n-diméthyl-4-phényl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4-b]indol]-4-amine
JP2015510956A (ja) 2012-03-14 2015-04-13 メディパックス インコーポレイテッド 過剰反応性分子を含むスマートポリマー材料
DE102012205493A1 (de) * 2012-04-03 2013-10-10 Acino Ag Einen Dopamin-Agonisten enthaltendes transdermales Applikationssystem
AR095259A1 (es) * 2013-03-15 2015-09-30 Noven Pharma Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
EP3007685A1 (fr) 2013-06-14 2016-04-20 tesa Labtec GmbH Système thérapeutique transdermique (tts) à trois couches
EP3054935B1 (fr) 2013-10-07 2020-12-09 Teikoku Pharma USA, Inc. Méthodes et compositions permettant de traiter le trouble d'hyperactivité avec déficit de l'attention, l'anxiété et l'insomnie à l'aide de compositions transdermiques de dexmédétomidine
RU2648449C2 (ru) 2013-10-07 2018-03-26 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Способы и композиции для трансдермальной доставки неседативного количества дексмедетомидина
JP6188934B2 (ja) * 2013-10-07 2017-08-30 テイコク ファーマ ユーエスエー インコーポレーテッド デクスメデトミジン経皮組成物を含む疼痛管理用方法及び組成物
KR101827980B1 (ko) * 2013-10-07 2018-02-13 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치 및 이의 사용 방법
DE102014000200A1 (de) 2014-01-03 2015-07-09 Michael Horstmann Transdermales Therapeutisches System
CN113874409A (zh) * 2019-07-11 2021-12-31 汉高知识产权控股有限责任公司 丙烯酸类聚合物和粘合剂组合物
SE1951054A1 (en) * 2019-09-18 2021-03-19 Enorama Pharma Ab Nicotine pouch

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3532708A (en) * 1967-11-02 1970-10-06 Monsanto Co Crosslinkable pressure-sensitive adhesive resins
US3558574A (en) 1968-12-09 1971-01-26 Johnson & Johnson Acrylated adhesive products
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
DE2915887A1 (de) 1979-04-19 1980-11-06 Wacker Chemie Gmbh Copolymerisate auf der basis von acrylestern, vinylacetat und aethylen
US4291015A (en) 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
US4286592A (en) 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
US4314557A (en) 1980-05-19 1982-02-09 Alza Corporation Dissolution controlled active agent dispenser
US4379454A (en) 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4497941A (en) 1981-10-16 1985-02-05 Exxon Research & Engineering Co. Ethylene copolymers for hot melt systems
US5310559A (en) 1982-09-01 1994-05-10 Hercon Laboratories Corporation Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer
US4554324A (en) 1982-09-16 1985-11-19 Minnesota Mining And Manufacturing Co. Acrylate copolymer pressure-sensitive adhesive composition and sheet materials coated therewith
US4608249A (en) * 1982-11-02 1986-08-26 Nitto Electric Industrial Co., Ltd. Hydrophilic therapeutic material
US4704282A (en) 1984-06-29 1987-11-03 Alza Corporation Transdermal therapeutic system having improved delivery characteristics
US4725439A (en) 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US4626539A (en) 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4568343A (en) 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
US4597961A (en) 1985-01-23 1986-07-01 Etscorn Frank T Transcutaneous application of nicotine
JPH0747535B2 (ja) 1985-11-26 1995-05-24 日東電工株式会社 消炎鎮痛用貼付剤
US4954343A (en) 1986-03-29 1990-09-04 Nitto Electric Industrial Co., Ltd. Dermal pharmaceutical preparations
US4908027A (en) 1986-09-12 1990-03-13 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US5344656A (en) 1986-09-12 1994-09-06 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
AU601528B2 (en) 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
US5006342A (en) 1986-12-22 1991-04-09 Cygnus Corporation Resilient transdermal drug delivery device
US4906463A (en) 1986-12-22 1990-03-06 Cygnus Research Corporation Transdermal drug-delivery composition
US4822676A (en) 1987-03-16 1989-04-18 National Starch And Chemical Corporation Pressure sensitive adhesive compositions for use on vinyl substrates
US5186939A (en) 1987-04-23 1993-02-16 Cygnus Therapeutic Systems Laminated composite for transdermal administration of fentanyl
US4839174A (en) 1987-10-05 1989-06-13 Pharmetrix Corporation Novel transdermal nicotine patch
US4943435A (en) 1987-10-05 1990-07-24 Pharmetrix Corporation Prolonged activity nicotine patch
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5004610A (en) 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5364630A (en) 1988-06-14 1994-11-15 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US4908213A (en) 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine
US5230896A (en) 1989-10-12 1993-07-27 Warner-Lambert Company Transdermal nicotine delivery system
US5077104A (en) 1989-12-21 1991-12-31 Alza Corporation Nicotine packaging materials
US5508038A (en) 1990-04-16 1996-04-16 Alza Corporation Polyisobutylene adhesives for transdermal devices
CA2039586A1 (fr) * 1990-05-02 1991-11-03 Marian R. Appelt Adhesifs reticules sensibles a la pression et tolerants aux excipients a base d'alcool utilises dans les dispositifs transdermiques et methode de preparation connexe
US5152997A (en) 1990-12-11 1992-10-06 Theratech, Inc. Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
US5164190A (en) 1990-12-11 1992-11-17 Theratech, Inc. Subsaturated transdermal drug delivery device exhibiting enhanced drug flux
US5135753A (en) 1991-03-12 1992-08-04 Pharmetrix Corporation Method and therapeutic system for smoking cessation
DE4310012A1 (de) 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
US5762952A (en) 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
US5613958A (en) 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
EP0721348B1 (fr) 1993-09-29 1999-09-01 Alza Corporation Renforcateur de permeation a base de monoglyceride/lactate
WO1996008229A2 (fr) * 1994-09-14 1996-03-21 Minnesota Mining And Manufacturing Company Matrice pour une administration transdermique d'un medicament
US5573778A (en) 1995-03-17 1996-11-12 Adhesives Research, Inc. Drug flux enhancer-tolerant pressure sensitive adhesive composition
US5882676A (en) 1995-05-26 1999-03-16 Alza Corporation Skin permeation enhancer compositions using acyl lactylates
US5785991A (en) 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US5693335A (en) * 1995-06-07 1997-12-02 Cygnus, Inc. Skin permeation enhancer composition for use with sex steroids
TW411277B (en) 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
US6512010B1 (en) 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
US5985317A (en) 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
WO1998017315A2 (fr) 1996-10-24 1998-04-30 Alza Corporation Agents facilitant la permeation et destines a des compositions, des dispositifs et des procedes d'apport transdermique de medicaments
US6246904B1 (en) 1996-12-17 2001-06-12 Alza Corporation Electrotransport drug delivery reservoirs containing inert fillers
DE19653606A1 (de) 1996-12-20 1998-06-25 Roehm Gmbh Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher
DE19653605C2 (de) 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
US6203817B1 (en) 1997-02-19 2001-03-20 Alza Corporation Reduction of skin reactions caused by transdermal drug delivery
US7150881B2 (en) * 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
IT1294748B1 (it) 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
US6077527A (en) 1997-10-28 2000-06-20 National Starch And Chemical Investment Holding Corporation Enhancer tolerant pressure sensitive adhesives for transdermal drug delivery
WO2000024386A1 (fr) 1998-09-08 2000-05-04 Theratech, Inc. Procede de fabrication de timbres matriciels autocollants contenant des sels hydrophiles de medicaments
ATE447398T1 (de) 1998-12-18 2009-11-15 Alza Corp Durchsichtige transdermale nicotinabgabevorrichtungen
EP1061900B2 (fr) 1999-01-14 2008-07-09 Noven Pharmaceuticals, Inc. Compositions et procedes pour l'administration de medicament
MXPA01007702A (es) * 1999-01-29 2002-11-04 Strakan Ltd Adhesivos.
EP1161230B1 (fr) 1999-03-18 2003-10-29 LTS Lohmann Therapie-Systeme AG Systeme transdermique therapeutique et son procede de production
KR100622332B1 (ko) * 1999-04-01 2006-09-13 알자 코포레이션 폴리우레탄 약물 리저버를 함유하는 경피 약물 수송 장치
KR20010036685A (ko) 1999-10-11 2001-05-07 김윤 펜타닐을 함유하는 매트릭스형 경피투여제
US6558790B1 (en) 1999-11-30 2003-05-06 Avery Dennison Corporation Water vapor-permeable, pressure-sensitive adhesives
ES2410532T3 (es) 2000-09-19 2013-07-02 Henkel Ag & Co. Kgaa Adhesivo de acrilo útil en sistemas de administración transdérmica de fármacos
US20020119187A1 (en) 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
GB0026137D0 (en) 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
MXPA03008349A (es) * 2001-03-16 2004-10-15 Johnson & Johnson Parche transdermico para administrar fentanilo.
ES2377672T3 (es) 2001-05-01 2012-03-29 Euro-Celtique S.A. Sistemas transdérmicos resistentes al abuso que contienen opioides
US20030002682A1 (en) 2001-07-02 2003-01-02 Phonex Broadband Corporation Wireless audio/mechanical vibration transducer and audio/visual transducer
US7645813B2 (en) * 2001-08-10 2010-01-12 Cosmed Pharmaceutical Co., Ltd. Pressure-sensitive adhesive for the skin and tapes or sheets for the skin made by using the same
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US20040033253A1 (en) 2002-02-19 2004-02-19 Ihor Shevchuk Acyl opioid antagonists
DK1480625T3 (da) 2002-03-06 2008-10-27 Hexal Ag Transdermalt system med fentanyl
JP4323138B2 (ja) * 2002-06-05 2009-09-02 日東電工株式会社 経皮吸収型製剤およびその製造方法
US20070098766A1 (en) * 2003-06-24 2007-05-03 Saitama Daiichi Pharmaceutical Co., Ltd. Nonaqueous pressure-sensitive adhesive for medicinal tape preparation for percutaneous absorption, medicinal tape preparation for percutaneous asorption, and process for producing the same
JP4724368B2 (ja) * 2004-01-07 2011-07-13 コスメディ製薬株式会社 粘着剤組成物および貼付剤
WO2006124584A2 (fr) * 2005-05-13 2006-11-23 Alza Corporation Systeme d'administration de medicaments a couches multiples equipe d'une protection contre l'ecoulement de matiere de reservoir
WO2007035940A2 (fr) 2005-09-23 2007-03-29 Alza Corporation Systeme d'administration de norelgestromine par voie transdermique
US8383149B2 (en) 2005-09-23 2013-02-26 Alza Corporation High enhancer-loading polyacrylate formulation for transdermal applications

Also Published As

Publication number Publication date
US20160051488A1 (en) 2016-02-25
EP2308480B1 (fr) 2014-08-13
US20070098771A1 (en) 2007-05-03
US9446004B2 (en) 2016-09-20
US20150246007A1 (en) 2015-09-03
EP2308480A2 (fr) 2011-04-13
US8383149B2 (en) 2013-02-26
EP2308480A3 (fr) 2011-10-05
EP1948142B1 (fr) 2014-04-09
US20130172428A1 (en) 2013-07-04
WO2007035939A2 (fr) 2007-03-29
US20140249125A1 (en) 2014-09-04
US8758808B2 (en) 2014-06-24
WO2007035939A3 (fr) 2007-05-31
EP1948142A2 (fr) 2008-07-30
US9205090B2 (en) 2015-12-08

Similar Documents

Publication Publication Date Title
HK1156512A1 (en) High enhancer-loading polyacrylate formulation for transdermal applications
IL250108A0 (en) Heteroaryl compounds and their uses
IL244442B (en) Compounds of converted acylanilides and their use
EP2214486A4 (fr) Composés hétéroaryles et leurs utilisations
ZA200707650B (en) Azolylacylguanidines as ß-secretase inhibitors
PT2114900T (pt) Compostos à base de tiopirimidina e as suas utilizações
IL189856A0 (en) New formulation
ZA200802602B (en) Controlled release formulation
TWI370115B (en) New formulation
EP2125920A4 (fr) Composés amine à haute fonctionnalité et utilisations de ceux-ci
GB0720716D0 (en) Novel formulation
GB0526419D0 (en) Formulation
GB0621160D0 (en) Compounds and uses thereof
EP2024366A4 (fr) Composés d'hétéroaryle monocyclique
PL1915482T3 (pl) Zespoły zabezpieczające dla podłoży zabezpieczających
GB0517673D0 (en) Formulation
GB0625312D0 (en) Formulation
EP2124908A4 (fr) Composés et utilisations de ceux-ci
IL184737A0 (en) Anthelmintic composition
EP1849481A4 (fr) Préparation à usage externe
GB0717189D0 (en) Novel processes and compounds
EP2120563A4 (fr) Composés et leurs utilisations
GB0501030D0 (en) Formulation
EP2099459A4 (fr) Composés et leurs utilisations
PL1928232T3 (pl) Stała formulacja

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210924